StonvexLoading…
StonvexStonvexStonvexCore line items from PTCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $272.55M | $1.73B | $1.57B | $1.35B |
Operating Income | $44.96M | $866.93M | $938.28M | $935.27M |
Net Income | $-2.81M | $682.64M | $817.61M | $801.71M |
EPS (Diluted) | $-0.03 | $7.78 | $9.45 | $9.29 |
Total Assets | $2.87B | $2.90B | $2.64B | $2.63B |
Total Liabilities | $3.05B | $3.10B | $2.80B | $2.84B |
Cash & Equivalents | $833.99M | $984.65M | $672.62M | $1.02B |
Free Cash Flow OCF − CapEx | $-60.24M | $702.34M | $738.98M | $808.73M |
Shares Outstanding | 82.88M | 81.47M | 79.93M | 79.38M |